370 related articles for article (PubMed ID: 12597352)
21. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
22. Current treatment approaches for infants with malignant central nervous system tumors.
Lafay-Cousin L; Strother D
Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475
[TBL] [Abstract][Full Text] [Related]
23. [A case of recurrent medulloblastoma treated by combination therapy with cisplatinum and tetrahydropyranyladriamycin (PP therapy)].
Seike M; Honda S; Moriki A; Nakai K; Sada Y; Arisawa M; Kurisaka M; Mori K
Gan To Kagaku Ryoho; 1991 May; 18(6):1043-5. PubMed ID: 2029190
[TBL] [Abstract][Full Text] [Related]
24. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
25. Childhood medulloblastoma: current status of biology and treatment.
Klesse LJ; Bowers DC
CNS Drugs; 2010 Apr; 24(4):285-301. PubMed ID: 20297854
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice.
Friedman HS; Schold SC; Varia M; Bigner DD
Cancer Res; 1983 Jul; 43(7):3088-93. PubMed ID: 6850617
[TBL] [Abstract][Full Text] [Related]
28. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
[TBL] [Abstract][Full Text] [Related]
29. Development of chemotherapy treatment for pediatric brain tumors.
Horowitz ME; Poplack DG
Neurol Clin; 1991 May; 9(2):363-73. PubMed ID: 1944105
[TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
31. Cerebellopontine angle medulloblastoma.
Nyanaveelan M; Azmi A; Saffari M; Banu SK; Suryati MY; Jeyaledchumy M
Med J Malaysia; 2007 Jun; 62(2):173-4. PubMed ID: 18705459
[TBL] [Abstract][Full Text] [Related]
32. [Radiotherapy of medulloblastoma combined with OK-432 (picibanil)--utilization of its alleviating action on radiation-induced myelosuppression].
Aoki Y
Nihon Gan Chiryo Gakkai Shi; 1986 Aug; 21(7):1376-85. PubMed ID: 3782983
[No Abstract] [Full Text] [Related]
33. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
Brandes AA; Franceschi E; Tosoni A; Blatt V; Ermani M
Cancer; 2007 Nov; 110(9):2035-41. PubMed ID: 17823910
[TBL] [Abstract][Full Text] [Related]
34. Brain tumors in children. III. Advances in chemotherapy.
Finlay JL; Goins SC
Am J Pediatr Hematol Oncol; 1987; 9(3):264-71. PubMed ID: 2823626
[TBL] [Abstract][Full Text] [Related]
35. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
36. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
[TBL] [Abstract][Full Text] [Related]
37. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
38. Secondary acute lymphoblastic leukemia in a child three years after treatment for medulloblastoma.
Casteels K; Renard M; Van Gool S; Uyttebroeck A
Med Pediatr Oncol; 2001 Mar; 36(3):390-1. PubMed ID: 11241444
[No Abstract] [Full Text] [Related]
39. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma.
Kocsis B; Székely G; Pap L; Németh G
Strahlenther Onkol; 2003 Dec; 179(12):854-9. PubMed ID: 14652675
[TBL] [Abstract][Full Text] [Related]
40. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
Francis D; Richards GM; Forouzannia A; Mehta MP; Khuntia D
Expert Opin Pharmacother; 2009 Sep; 10(13):2171-80. PubMed ID: 19640206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
